Suicide prevention research projects - University of the Sunshine Coast, Queensland, Australia

Accessibility links

Suicide prevention research projects

Suicidality is a significant public health problem that results in morbidity, loss of individual life, potential grief to loved ones, and significant healthcare expenditure.

The Thompson Institute is conducting world-leading research to prevent suicide. This includes clinical trials of novel treatments for suicidality, and research addressing four components of suicide prevention:

  1. Promoting health and wellbeing
  2. Supporting people who are upset
  3. Mental health assessment
  4. Evidence-based interventions

Get involved

Research open to public participation

Outcomes

What our research has discovered

Stethoscope on clipboard

Clinical Trial - Novel treatment of suicidality

This study found that oral doses of ketamine administered in a clinical setting can provide a rapid-acting treatment for chronic suicidality.

Learn more...

Other research projects

  • Evaluation of a new approach to supporting people who have suicidal thoughts (led by Gabe Hart)
  • Improving mental healthcare assessment (led by Professor Helen Stallman)
  • Effect of unhealthy coping on cognition in young adolescents (Led by Ruby Billings)
  • Understanding barriers to help-seeking for mental health problems (led by Tim Kelly)
  • Measurement of suicidality (led by Kim Woods)
  • The trajectory of suicidality in early adolescence (led by Kylie Van Doren)
  • Wellbeing of Paramedics (led by Professor Helen Stallman)
  • Effect of developmental competencies on health behaviours (led by Rebekah Van Der Kooy)
  • Developmental Interpersonal Trauma Disorder (led by Professor Helen Stallman)
  • Psychometric Properties of the Parenting Efficacy Index (led by Richard Bojack)
  • Developmental competencies and Parenting Efficacy
  • Effectiveness of Creative Writing to Improve Developmental Competencies
  • Evaluation of Coping Kids to prevent mental illness and suicide

Research contacts

Research: Professor Helen Stallman
Clinical trials: Megan Dutton
Partnerships: Mervat Quirke